Skip to main content
. 2025 Jan 3;74(2):73. doi: 10.1007/s00262-024-03923-y

Fig. 2.

Fig. 2

Manufacture and validation of aErbB3 CAR-NK cells using cord blood-derived NK cells. A Schematic diagram depicting the construction of the second-generation aCD19 CAR and aErbB3 CAR encoded in a pCDH lentiviral vector with an MSCV promoter (left). Bar graph of the titer of the lentivirus produced (right). B Schematic representation of CAR-NK production from cord blood-derived NK cells and subsequent evaluation. C Representative flow cytometric analysis of CAR expression in CD3CD56.+ subsets 3 days post-transduction (left). Summary data is presented as a scatter plot of the percentage of CAR expression in the non-transduced (UTD) and transduced cells (n = 9, mean ± SD) (right). D Determination of maintaining aCD19 CAR and aErbB3 CAR expression on transduced NK cells. E ELISA analysis of IL-15 secretion in aCD19 CAR-NK cells and aErbB3 CAR-NK cells. Control: Culture medium of non-transduced NK cells, P2A + GFP: culture medium of NK cells transduced with CAR lentivirus (P2A + GFP). P2A + IL-15: culture medium of NK cells transduced with CAR lentivirus (P2A + IL-15)